(2026). Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Pan-cancer Analysis Identifies APOC1 as a TAM-derived Modulator of Adaptive Immune Resistance and Predictor of Therapeutic Response."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Pan-cancer Analysis Identifies APOC1 as a TAM-derived Modulator of Adaptive Immune Resistance and Predictor of Therapeutic Response."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.